Immunotherapy -- targeted drug combination improves survival in advanced kidney cancer ...Middle East

- News
Immunotherapy -- targeted drug combination improves survival in advanced kidney cancer
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

Hence then, the article about immunotherapy targeted drug combination improves survival in advanced kidney cancer was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy -- targeted drug combination improves survival in advanced kidney cancer )

Apple Storegoogle play

Last updated :

Also on site :



Latest News